The battle over the legalities of cannabidiol (CBD) oil has been going on for years. The fight has been tough, and the casualties brutal. Some say the general public should be allowed to utilize CBD oil, and others say it should only be entrusted to big pharmacies. In the midst of it all, the question regarding the exact origin of CBD oil and its relation to marijuana seems to puzzle even the best of us. Recently the federal court ruled against CBD, making a clear statement that, to no surprise, the U.S. government seems to be in favor of big pharma.
The Federal Court Ruled Against CBD Extract
In August 2018 the hemp industry lost an important appeal that is negatively impacting the availability of CBD oil today. The federal court ruled against CBD and sided with the Drug Enforcement Administration (DEA) in their decision to categorize CBD as a Schedule I substance under the Controlled Substances Act. In other words, the federal court believes CBD oil has no medicinal value, is not considered safe for general consumption, and should be under the same legal limitations as marijuana and heroin. (6)…
How is it possible that the DEA is a party to a lawsuit which affects their own administrative domain? Wouldn’t it be nice to write your own job description? DEA: “But it’s our job to throw people in jail and steal their homes and vehicles for no reason! You don’t want to put us out of a job do you? And while we’re at it, why not make vitamin C a controlled substance too?”
…She was arrested without a warrant and held in jail for 5 days without the opportunity for bail as a fugitive from justice, and was given a 4-year gag order. Her career was destroyed. Her story is documented in the book Plague: One Scientist’s intrepid Search For the Truth about Human Retroviruses and Chronic Fatigue Syndrome, Autism, and Other Diseases.
Ironically, the FDA has now approved a testing protocol to detect retroviruses in the U.S. blood supply which is worth millions of dollars, and based in large part on Dr. Mikovits’ research, but it is being managed by Big Pharma. So while this distinguished scientist is now bankrupt and without employment, others are allegedly capitalizing on her research to earn millions of dollars to clean up the U.S. blood supply….
In a move that has been slammed by opponents, the US Food and Drug Administration (FDA) has lifted an import alert that prevented controversial genetically engineered salmon from entering the US market.
The long running battle previously came to a head in 2016 when Congress blocked the FDA from allowing AquaAdvantage Salmon to appear in grocery stores after the food watchdog declared the product, which critics have dubbed “frankenfish,” safe to eat.
That year also saw Congress pass a law directing the US Department of Agriculture to set a national mandatory standard for disclosing genetically modified foods.
The USDA finally issued the guidelines in December 2018. It uses the term ‘bioengineered’ instead of the more commonly used ‘genetically modified’ or ‘genetically engineered’, and allows ‘bioengineered’ ingredients to be disclosed in several different ways: in text, a symbol, a digital link printed on packaging, or text message….